School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Launched by UNIVERSITY OF ARKANSAS · Oct 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help children in rural Alaska who may have hearing loss. It aims to improve the follow-up care for kids who fail initial hearing screenings at school. The trial will test a program called STAR, which uses telemedicine to connect families directly with hearing specialists, making it easier for them to get the care they need. The researchers will be working with schools in three areas—Kodiak, Petersburg, and Lower Yukon—over three academic years, from 2023 to 2026.
Children from kindergarten through 12th grade who are enrolled in the participating schools are eligible to join the trial. No matter their age, gender, or background, any student who is screened for hearing issues at school can take part. If your child is included, they will first have an enhanced hearing screening at school, and then, if needed, they will be referred to a specialist through the STAR program. This approach aims to ensure that more children receive the follow-up care they need, helping to prevent long-term problems related to hearing loss.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in one of the participating schools in the 3 regions
- • Children from grades (K-12) that are typically screened within participating schools
- • Eligible regardless of age, gender, race, or ethnicity
- Exclusion Criteria:
- • N/A
About University Of Arkansas
The University of Arkansas is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to excellence in research and education, the university facilitates a collaborative environment that encourages interdisciplinary studies and the development of cutting-edge therapies. Its clinical trial programs leverage state-of-the-art facilities and expert faculty, aiming to improve patient outcomes and contribute to the body of medical knowledge. The university fosters partnerships with healthcare providers and industry stakeholders, ensuring rigorous ethical standards and adherence to regulatory requirements in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anchorage, Alaska, United States
Patients applied
Trial Officials
Matthew Hirschfeld, MD,PhD
Principal Investigator
Vice President-Specialty Services, Southcentral Foundation, Alaska Native Medical Center
Susan Emmett, MD, MPH
Principal Investigator
University of Arkansas Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials